Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Meibohm

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shockPavan K Vaddady, Nitin Mehrotra, Xiaofeng Zhang, et al.
British Journal of Clinical Pharmacology|August 1, 2017
Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjectsS Casey Laizure, Bernd Meibohm, Kembral Nelson, et al.
Molecular Nutrition & Food Research|December 8, 2015
Urinary metabolites from mango (Mangifera indica L. cv. Keitt) galloyl derivatives and in vitro hydrolysis of gallotannins in physiological conditionsRyan C Barnes, Kimberly A Krenek, Bernd Meibohm, et al.
Plos One|November 28, 2022
Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosisBing Yang, Robert B Parker, Bernd Meibohm, et al.
Journal of Clinical Pharmacology|February 25, 2015
Challenges and considerations for development of therapeutic proteins in pediatric patientsYi Zhang, Xiaohui Wei, Gaurav Bajaj, et al.
Journal of Clinical Pharmacology|February 18, 2021
Use of Real-World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of AgePradeep B Lukka, Megan Woods, Rebecca Chhim, et al.
Journal of Clinical Pharmacology|February 24, 2006
G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expressionPengfei Song, Jatinder K Lamba, Lijun Zhang, et al.
The AAPS Journal|May 16, 2025
Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, ErenumabParidhi Gupta, Ashish Srivastava, Josiah T Ryman, et al.
Pharmaceutical Research|June 16, 2017
Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding StudiesNarasimha M Midde, Yuqing Gong, Theodore J Cory, et al.
Plos One|February 13, 2016
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS MethodNarasimha M Midde, Mohammad A Rahman, Chetan Rathi, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shockPavan K Vaddady, Nitin Mehrotra, Xiaofeng Zhang, et al.
British Journal of Clinical Pharmacology|August 1, 2017
Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjectsS Casey Laizure, Bernd Meibohm, Kembral Nelson, et al.
Molecular Nutrition & Food Research|December 8, 2015
Urinary metabolites from mango (Mangifera indica L. cv. Keitt) galloyl derivatives and in vitro hydrolysis of gallotannins in physiological conditionsRyan C Barnes, Kimberly A Krenek, Bernd Meibohm, et al.
Plos One|November 28, 2022
Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosisBing Yang, Robert B Parker, Bernd Meibohm, et al.
Journal of Clinical Pharmacology|February 25, 2015
Challenges and considerations for development of therapeutic proteins in pediatric patientsYi Zhang, Xiaohui Wei, Gaurav Bajaj, et al.
Journal of Clinical Pharmacology|February 18, 2021
Use of Real-World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of AgePradeep B Lukka, Megan Woods, Rebecca Chhim, et al.
Journal of Clinical Pharmacology|February 24, 2006
G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expressionPengfei Song, Jatinder K Lamba, Lijun Zhang, et al.
The AAPS Journal|May 16, 2025
Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, ErenumabParidhi Gupta, Ashish Srivastava, Josiah T Ryman, et al.
Pharmaceutical Research|June 16, 2017
Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding StudiesNarasimha M Midde, Yuqing Gong, Theodore J Cory, et al.
Plos One|February 13, 2016
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS MethodNarasimha M Midde, Mohammad A Rahman, Chetan Rathi, et al.
Pageof 18